Sun Pharma successfully removed an injunction on the launch of its Leqselvi for alopecia areata, a common form of hair loss, in the US. The importance of biosimilars only continues to grow ...

Sun Pharma successfully removed an injunction on the launch of its Leqselvi for alopecia areata, a common form of hair loss, in the US.

USFDA, via email communication dated 11th April, 2025 (received by Medispray), has classified the inspection at the ...

Divi's Laboratories Limited has announced the signing of long-term manufacturing and supply agreement with a global pharma company for manufacturing and supply of advanced intermediates.

On the net interest income (NII) front, analysts remain divided and see the growth between -7.6 per cent and 9 per cent Y-o-Y.

The individual AUM of investors in B-30 surged 27 per cent in FY25, reaching ₹10.8 trn. In comparison, AUM in the top 30 cities (T-30) increased by 21 per cent to ₹30.5 trn during the same period ...